World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Will Stem Cell Clinics Flourish Under RFK Jr.?

Will Stem Cell Clinics Flourish Under RFK Jr.?

by admin | Mar 26, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By by Rachael Robertson MedPageToday – After HHS Secretary Robert F. Kennedy Jr. hosted a roundtableopens in a new tab or window on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential flourishing of questionable...
Clinical Trial Tests Novel Stem Cell Treatment for Parkinson’s Disease

Clinical Trial Tests Novel Stem Cell Treatment for Parkinson’s Disease

by admin | Mar 25, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Technology Networks – Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson’s treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking...
Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson’s Disease

Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson’s Disease

by admin | Mar 24, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Mass General Brigham – A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace...
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

by admin | Mar 21, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Frank Vinluan – MedCity News – Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder....
Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease

Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease

by admin | Mar 20, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Morgridge Institute for Research – MedicalXpress – Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and...
New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers

New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers

by admin | Mar 19, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Laura Kelley – University of Colorado Cancer Center – Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called...
Page 9 of 178« First«...7891011...203040...»Last »

Recent Posts

  • New Cell Therapy For Resistant Hodgkins Patients
  • Cracking the code to scalable cell and gene therapy
  • Gene-edited stem cells aim to reverse rheumatoid arthritis
  • One step closer to 3D printing inside the body
  • Stem cell transplant transforms life of toddler with beta thalassemia major
  • An Avatar for Studying Human Health: Tissue Chips
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow